Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 9, Pages 1173-1182
Publisher
Springer Nature
Online
2012-04-16
DOI
10.1038/onc.2012.128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
- (2011) F. M. Buffa et al. CANCER RESEARCH
- Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition
- (2011) Xiaoyan Li et al. CANCER SCIENCE
- Epigenetic regulation of microRNA-375 and its role in melanoma development in humans
- (2011) Joseph Mazar et al. FEBS LETTERS
- MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor
- (2011) Kar Lok Kong et al. GUT
- Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
- (2011) A Bergamaschi et al. ONCOGENE
- MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
- (2011) L Sun et al. ONCOGENE
- miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
- (2011) Espen Enerly et al. PLoS One
- MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3
- (2010) Y. Tsukamoto et al. CANCER RESEARCH
- Epigenetically Deregulated microRNA-375 Is Involved in a Positive Feedback Loop with Estrogen Receptor in Breast Cancer Cells
- (2010) P. de Souza Rocha Simonini et al. CANCER RESEARCH
- Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance
- (2009) Özgür Sahin et al. BMC Systems Biology
- MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
- (2009) Guohong Hu et al. CANCER CELL
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells
- (2009) Mi Ra Kim et al. CANCER SCIENCE
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Epithelial mesenchymal transition traits in human breast cancer cell lines
- (2008) T. Blick et al. CLINICAL & EXPERIMENTAL METASTASIS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
- (2008) Yannick Ladeiro et al. HEPATOLOGY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now